Theophylline for Treatment of Pseudohypoparathyroidism

Pseudohypoparathyroidism

Disorders of Bone and Mineral Metabolism QoL and Cognitive Function in Patients With Hypoparathyroidism Theophylline Treatment for Pseudohypoparathyroidism – Children 2-12 Years Old Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments Hypoparathyroidism in Denmark Physiologic Regulation of FGF-23 Theophylline for Treatment of Pseudohypoparathyroidism Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy) Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia) Theophylline Treatment for Pseudohypoparathyroidism Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a Glucose Homeostasis in Pseudohypoparathyroidism